Corrigendum to “Transcriptomic data of Bevacizumab-adapted colorectal adenocarcinoma cells HCT-116” [Data In Brief, Volume 48, (Available online 17 March 2023) 1-9/Article 109069]

• Cesare Sala,
• Tiziano Lottini,
• Elena Lastraioli,
• Federico Alessandro Ruffinatti,
• Luca Visentin,
• Annarosa Arcangeli

Affiliations

Cesare Sala

Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy

Tiziano Lottini

Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy

Elena Lastraioli

Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy; Complex Dynamics Study Centre (CSDC), University of Florence, 50100 Florence, Italy

Federico Alessandro Ruffinatti

Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Torino, Italy

Luca Visentin

Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Torino, Italy

Annarosa Arcangeli

Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy; Complex Dynamics Study Centre (CSDC), University of Florence, 50100 Florence, Italy; Corresponding author at: Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134 Florence, Italy. Complex Dynamics Study Centre (CSDC), University of Florence, 50100 Florence, Italy.